DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation

Information source: Seoul St. Mary's Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Coagulation; Intravascular

Intervention: Continuous heparin infusion (Drug); Intermittent heparin infusion (Drug)

Phase: Phase 3

Status: Recruiting

Sponsored by: Seoul St. Mary's Hospital

Official(s) and/or principal investigator(s):
Yong Seog Oh, MD, Principal Investigator, Affiliation: Seoul St. Mary's Hospital

Overall contact:
Yong Seog Oh, MD, Phone: 82-2-2258-1141, Email: oys@catholic.ac.kr

Summary

Optimal anticoagulation using heparin with close attention to maintain therapeutic dosing during the procedure is important. Randomized comparison of continuous and intermittent heparin infusion during catheter ablation of Atrial Fibrillation.

Clinical Details

Official title: Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Primary outcome: therapeutic ACT retention rate during procedure

Detailed description: Intravenous heparin was used during the procedure to prevent catheter-induced thrombosis. heparin is administered during the procedure to achieve recommended activation clotting times (ACT) values, typically >300 seconds to prevent thromboemboli during the procedure. Most of the practitioners was that ACT level should be checked at 30- to 60-minute intervals and then have injected intermittently. intermittent heparin infusion, concentration is great changed because the heparin has 30minutes half-period. researchers postulate that a constant therapeutic concentrations would be beneficial to continuous infusion than intermittent infusion.

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Atrial Fibrillation, Radiofrequency catheter ablation scheduled

Exclusion Criteria:

- Clinical trial denied

Locations and Contacts

Yong Seog Oh, MD, Phone: 82-2-2258-1141, Email: oys@catholic.ac.kr

Seoul st. mary's hospital, Seoul, Korea, Republic of; Recruiting
Additional Information

Starting date: December 2012
Last updated: May 23, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017